19:00 EST Ionis Pharmaceuticals (IONS) trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Ionis Pharmaceuticals trading halted, news pending
- Ionis Pharmaceuticals management to meet with Oppenheimer
- Theratechnologies enters exclusive licensing agreement with Ionis
- Ionis added to Analyst Current Favorites list at Raymond James
- Ionis Pharmaceuticals price target lowered to $62 from $65 at Piper Sandler